KFA
BSX icon

Krane Funds Advisors’s Boston Scientific BSX Stock Holding History

Krane Funds Advisors’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.15M Buy
27,000
+7,100
+36% +$386K 0.04% 96
2026
Q1 		$1.24M Buy
19,900
+4,000
+25% +$320K 0.05% 92
2025
Q4 		$1.52M Buy
+15,900
New +$1.56M 0.05% 59

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Krane Funds Advisors's BSX Position: Q2 2026 in Review

Krane Funds Advisors increased its Boston Scientific (BSX) stake by 36% in Q2 2026, buying an estimated $386K and bringing the position to 27,000 shares worth $1.15M. The position accounts for 0.04% of the portfolio, ranked #96.

Krane Funds Advisors first reported a position in BSX in Q4 2025 and has held it in 3 quarters since. The position peaked at $1.52M in Q4 2025. 1,477 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Krane Funds Advisors held 27,000 shares of Boston Scientific worth $1.15M as of Q2 2026.
  • Krane Funds Advisors bought 7,100 Boston Scientific shares in Q2 2026, an estimated $386K.
  • Boston Scientific made up 0.04% of Krane Funds Advisors's portfolio in Q2 2026, its #96 holding.
  • Krane Funds Advisors first reported a position in Boston Scientific in Q4 2025 and has held it in 3 quarters since.
  • Krane Funds Advisors's Boston Scientific position peaked at $1.52M in Q4 2025.
  • 1,477 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Krane Funds Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.